Goldman Sachs Group Inc Humacyte, Inc. Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 637,675 shares of HUMA stock, worth $975,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares

637,675

Previous 515,698 23.65%

Holding current value

$975,642

Previous $881,000 51.19%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	BUY	$1.15 - $2.77 $140,273 - $337,876	121,977 Added 23.65%	637,675 $1.33 Million
Q1 2025 May 09, 2025	SELL	$1.71 - $5.18 $191,567 - $580,305	-112,028 Reduced 17.85%	515,698 $881,000
Q4 2024 Feb 11, 2025	SELL	$3.46 - $5.81 $708,552 - $1.19 Million	-204,784 Reduced 24.6%	627,726 $3.17 Million
Q3 2024 Nov 14, 2024	BUY	$5.11 - $9.46 $362,477 - $671,045	70,935 Added 9.31%	832,510 $4.53 Million
Q2 2024 Aug 13, 2024	BUY	$2.87 - $9.1 $1.9 Million - $6.03 Million	662,723 Added 670.42%	761,575 $3.66 Million
Q1 2024 May 15, 2024	SELL	$2.57 - $4.84 $4,764 - $8,973	-1,854 Reduced 1.84%	98,852 $307,000
Q4 2023 Feb 13, 2024	SELL	$1.99 - $3.12 $63,329 - $99,290	-31,824 Reduced 24.01%	100,706 $286,000
Q3 2023 May 14, 2024	BUY	$2.75 - $4.48 $87,516 - $142,571	31,824 Added 31.6%	132,530 $388,000
Q3 2023 Nov 14, 2023	BUY	$2.75 - $4.48 $159,447 - $259,754	57,981 Added 77.78%	132,530 $388,000
Q2 2023 May 14, 2024	BUY	$2.86 - $4.97 $33,364 - $57,980	11,666 Added 18.55%	74,549 $213,000
Q2 2023 Aug 14, 2023	BUY	$2.86 - $4.97 $33,364 - $57,980	11,666 Added 18.55%	74,549 $213,000
Q1 2023 May 14, 2024	BUY	$2.11 - $3.25 $15,379 - $23,689	7,289 Added 13.11%	62,883 $194,000
Q1 2023 May 11, 2023	BUY	$2.11 - $3.25 $15,379 - $23,689	7,289 Added 13.11%	62,883 $194,000
Q4 2022 May 14, 2024	SELL	$2.02 - $3.62 $32,651 - $58,513	-16,164 Reduced 22.53%	55,594 $117,000
Q4 2022 Feb 13, 2023	SELL	$2.02 - $3.62 $32,651 - $58,513	-16,164 Reduced 22.53%	55,594 $117,000
Q3 2022 May 14, 2024	BUY	$1.22 - $5.14 $35,203 - $148,314	28,855 Added 67.26%	71,758 $234,000
Q3 2022 Nov 10, 2022	BUY	$1.22 - $5.14 $35,203 - $148,314	28,855 Added 67.26%	71,758 $233,000
Q2 2022 May 14, 2024	SELL	$3.21 - $7.86 $185,547 - $454,331	-57,803 Reduced 57.4%	42,903 $138,000
Q2 2022 Aug 15, 2022	SELL	$3.21 - $7.86 $170,332 - $417,075	-53,063 Reduced 55.29%	42,903 $138,000
Q1 2022 May 16, 2022	BUY	$4.65 - $7.4 $85,006 - $135,279	18,281 Added 23.53%	95,966 $678,000
Q4 2021 Feb 14, 2022	BUY	$7.25 - $11.6 $563,216 - $901,146	77,685 New	77,685 $563,000

Others Institutions Holding HUMA

# of Institutions

171

Shares Held

54.5M

Call Options Held

1.1M

Put Options Held

808K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $158M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Humacyte, Inc. Transaction History